Javascript must be enabled to continue!
Role of Fractional Exhaled Nitric Oxide for Monitoring Bronchial Asthma
View through CrossRef
Background: Monitoring during treatment of asthma is usually done by various clinical tools, spirometry, sputum eosinophils and fractional exhaled nitric oxide. Fractional exhaled nitric oxide is a simple and noninvasive tool and has a good agreement with asthma control test score. This study aims to correlate fractional exhaled nitric oxide with asthma control test score. Methods: This cross-sectional study was conducted at National Academy of Medical Sciences, Bir hospital, Chest unit, Department of Medicine, over a duration of six months. Patients aged more than 18 years with bronchial asthma diagnosed at least three months prior were included into the study. Those with recent severe exacerbations, known other chronic respiratory disease and smokers were excluded. Asthma control test score was obtained at baseline. All included patients underwent fractional exhaled nitric oxide measurement followed by measurement of Forced vital capacity(FVC) Forced expiratory volume in one second (FEV1) and FEV1/FVC ratio. Results: Forty patients with a mean age of 40.5±11.1 years were included in the study. Majority were females (65%) and the median duration of symptoms was 24 months (Interquartile range= 18-60). Mean fractional exhaled nitric oxide level was 27.8 (±16.0) parts per billion (ppb) and asthma control test score was 19.3 (±4.7). Mean fractional exhaled nitric oxide levels were significantly different across different severity (well controlled, partially controlled and poorly controlled) of asthma (p=0.013). The mean fractional exhaled nitric oxide values and total asthma control test score shows statistically significant negative correlation (Pearson correlation coefficient (r) = -0.462, p=0.003). Asthma control test and FeNO values guided the change of inhaled steroid dose in 17 of the 40 patients. Conclusion: Fractional exhaled nitric oxide can be used when available, along with asthma control test for monitoring control and adjusting the inhaled steroid dose in asthma. Keywords: Asthma control test (ACT); bronchial asthma; Fractional exhaled nitric oxide (FeNO).
Nepal Health Research Council
Title: Role of Fractional Exhaled Nitric Oxide for Monitoring Bronchial Asthma
Description:
Background: Monitoring during treatment of asthma is usually done by various clinical tools, spirometry, sputum eosinophils and fractional exhaled nitric oxide.
Fractional exhaled nitric oxide is a simple and noninvasive tool and has a good agreement with asthma control test score.
This study aims to correlate fractional exhaled nitric oxide with asthma control test score.
Methods: This cross-sectional study was conducted at National Academy of Medical Sciences, Bir hospital, Chest unit, Department of Medicine, over a duration of six months.
Patients aged more than 18 years with bronchial asthma diagnosed at least three months prior were included into the study.
Those with recent severe exacerbations, known other chronic respiratory disease and smokers were excluded.
Asthma control test score was obtained at baseline.
All included patients underwent fractional exhaled nitric oxide measurement followed by measurement of Forced vital capacity(FVC) Forced expiratory volume in one second (FEV1) and FEV1/FVC ratio.
Results: Forty patients with a mean age of 40.
5±11.
1 years were included in the study.
Majority were females (65%) and the median duration of symptoms was 24 months (Interquartile range= 18-60).
Mean fractional exhaled nitric oxide level was 27.
8 (±16.
0) parts per billion (ppb) and asthma control test score was 19.
3 (±4.
7).
Mean fractional exhaled nitric oxide levels were significantly different across different severity (well controlled, partially controlled and poorly controlled) of asthma (p=0.
013).
The mean fractional exhaled nitric oxide values and total asthma control test score shows statistically significant negative correlation (Pearson correlation coefficient (r) = -0.
462, p=0.
003).
Asthma control test and FeNO values guided the change of inhaled steroid dose in 17 of the 40 patients.
Conclusion: Fractional exhaled nitric oxide can be used when available, along with asthma control test for monitoring control and adjusting the inhaled steroid dose in asthma.
Keywords: Asthma control test (ACT); bronchial asthma; Fractional exhaled nitric oxide (FeNO).
Related Results
The Impact of Adverse Childhood Experiences on Asthma Severity in US Adults
The Impact of Adverse Childhood Experiences on Asthma Severity in US Adults
Background/objectives: The association between adverse childhood experiences (ACEs) and asthma severity among United States (US) adults with asthma has not been well documented. In...
Solving Undamped and Damped Fractional Oscillators via Integral Rohit Transform
Solving Undamped and Damped Fractional Oscillators via Integral Rohit Transform
Background: The dynamics of fractional oscillators are generally described by fractional differential equations, which include the fractional derivative of the Caputo or Riemann-Li...
Cometary Physics Laboratory: spectrophotometric experiments
Cometary Physics Laboratory: spectrophotometric experiments
<p><strong><span dir="ltr" role="presentation">1. Introduction</span></strong&...
ASTHMA AND RESPIRATORY SYMPTOMS RELATED TO THE ENVIRONMENT
ASTHMA AND RESPIRATORY SYMPTOMS RELATED TO THE ENVIRONMENT
Asthma, a ubiquitous chronic respiratory ailment, stands as a formidable global health concern, affecting millions of individuals across the world. This widespread condition, marke...
Prevalence of Comorbidities among United States Adults with asthma and Their Association with Asthma Severity
Prevalence of Comorbidities among United States Adults with asthma and Their Association with Asthma Severity
AbstractIntroductionThe burden of comorbidities in asthma patients significantly affects management strategies and outcomes. This study aimed to analyze the prevalence and trends o...
Management of Patients with Bronchial Asthma: GINA 2021
Management of Patients with Bronchial Asthma: GINA 2021
Бронхиальная астма является широко распространенным гетерогенным заболеванием легких, характеризующимся хроническим воспалением дыхательных путей, наличием изменяющихся по времени ...
MO928EXHALED HYDROGEN AS A MARKER OF INTESTINAL FERMENTATION IS ASSOCIATED WITH DIARRHEA IN KIDNEY TRANSPLANT RECIPIENTS
MO928EXHALED HYDROGEN AS A MARKER OF INTESTINAL FERMENTATION IS ASSOCIATED WITH DIARRHEA IN KIDNEY TRANSPLANT RECIPIENTS
Abstract
Background and Aims
Diarrhea is a common gastrointestinal (GI) complaint among kidney transplant recipients (KTR). Exha...
Quality of life and its relation to pediatric asthma severity
Quality of life and its relation to pediatric asthma severity
Abstract
Background
Bronchial asthma is a global health problem that negatively affects the quality of life (QOL) of both children and their caregiv...


